Literature DB >> 2995400

Application of restriction endonucleases as a tool for studying the action of 4-S-ethanolsulfido-cyclophosphamide on DNA with known sequences.

H Lindemann.   

Abstract

Lambda-DNA and plasmid pBR 322-DNA, respectively, were treated in vitro with increasing amounts of 4-S-ethanolsulfido-cyclophosphamide (CPA-P1). Subsequent digestion with restriction endonuclease Pvu II or Mbo II revealed discrete alterations in the cleavage patterns as compared to the controls, indicating subtle changes in DNA structure due to CPA-P1 interaction. In the case of pBR 322-DNA the CPA-P1 treatment of supercoiled circular DNA was more inhibitory to subsequent digestion as compared to the treatment of linearized plasmid DNA molecules.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995400     DOI: 10.1007/bf00402734

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  4 in total

1.  [Interaction of the three alkylating drugs, cyclophosphamide, ifosfamide and trofosfamide, with DNA and DNA-constituents in vitro (author's transl)].

Authors:  H Lindemann; E Harbers
Journal:  Arzneimittelforschung       Date:  1980

2.  A cautionary note on the use of certain restriction endonucleases with methylated substrates.

Authors:  K Backman
Journal:  Gene       Date:  1980-10       Impact factor: 3.688

3.  DNA protection with the DNA methylase M . BbvI from Bacillus brevis var. GB against cleavage by the restriction endonucleases PstI and PvuII.

Authors:  A P Dobritsa; S V Dobritsa
Journal:  Gene       Date:  1980-07       Impact factor: 3.688

4.  Interaction of cyclophosphamide with DNA in isolated rat liver cell nuclei.

Authors:  H Lindemann
Journal:  Anticancer Res       Date:  1984 Jan-Apr       Impact factor: 2.480

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.